 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, October 12, 2005, 25(41):9413-9417; doi:10.1523/JNEUROSCI.3190-05.2005
Previous Article | Next Article
Cellular/Molecular
D-Serine Is the Dominant Endogenous Coagonist for NMDA Receptor Neurotoxicity in Organotypic Hippocampal Slices
Maria Shleper, Elena Kartvelishvily, andHerman Wolosker Department of Biochemistry, B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel
D-serine occurs at high levels in the brain, where it is an endogenous coagonist at the "glycine site" of NMDA receptors. However, D-serine action has not been previously compared with that of endogenous glycine, and the relative importance of the two coagonists remains unclear. We now investigated the efficiencies of the two coagonists in mediating NMDA receptor neurotoxicity in organotypic hippocampal slices. Removal of endogenous D-serine from slices was achieved by pretreating the tissue with recombinant D-serine deaminase enzyme. This enzyme is several orders of magnitude more efficient than previous methods to remove D-serine. We report that complete removal of D-serine virtually abolished NMDA-elicited neurotoxicity but did not protect against kainate. Although levels of glycine were 10-fold higher than D-serine, endogenous glycine was ineffective in mediating NMDA receptor neurotoxicity. The effect of endogenous glycine could be observed only after simultaneous removal of endogenous D-serine and blockage of the glycine transporter GlyT1. Our data indicate that D-serine is the dominant coagonist for NMDA receptor-elicited neurotoxicity, mediating all cell death elicited by NMDA in organotypic slices. The results suggest an essential role for this unusual D-amino acid, with implications for the mechanism of neuronal death in the nervous system.
Key words: neuromodulation; neurotoxicity; neurotransmission; glutamate; neuroprotection; NMDA receptor
Received May 10, 2005; accepted August 29, 2005.
This article has been cited by other articles:
V. Labrie, R. Fukumura, A. Rastogi, L. J. Fick, W. Wang, P. C. Boutros, J. L. Kennedy, M. O. Semeralul, F. H. Lee, G. B. Baker, et al.
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model
Hum. Mol. Genet., September 1, 2009; 18(17): 3227 - 3243.
[Abstract] [Full Text] [PDF]
H. X. Zhang, K. Hyrc, and L. L. Thio
The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine
J. Physiol., July 1, 2009; 587(13): 3207 - 3220.
[Abstract] [Full Text] [PDF]
L. Balan, V. N. Foltyn, M. Zehl, E. Dumin, E. Dikopoltsev, D. Knoh, Y. Ohno, A. Kihara, O. N. Jensen, I. S. Radzishevsky, et al.
Feedback inactivation of D-serine synthesis by NMDA receptor-elicited translocation of serine racemase to the membrane
PNAS, May 5, 2009; 106(18): 7589 - 7594.
[Abstract] [Full Text] [PDF]
A. K. Mustafa, D. B. v. Rossum, R. L. Patterson, D. Maag, J. T. Ehmsen, S. K. Gazi, A. Chakraborty, R. K. Barrow, L. M. Amzel, and S. H. Snyder
Glutamatergic regulation of serine racemase via reversal of PIP2 inhibition
PNAS, February 24, 2009; 106(8): 2921 - 2926.
[Abstract] [Full Text] [PDF]
R. Inoue, K. Hashimoto, T. Harai, and H. Mori
NMDA- and {beta}-Amyloid1-42-Induced Neurotoxicity Is Attenuated in Serine Racemase Knock-Out Mice
J. Neurosci., December 31, 2008; 28(53): 14486 - 14491.
[Abstract] [Full Text] [PDF]
Z. Zhang, N. Gong, W. Wang, L. Xu, and T.-L. Xu
Bell-Shaped D-Serine Actions on Hippocampal Long-Term Depression and Spatial Memory Retrieval
Cereb Cortex, October 1, 2008; 18(10): 2391 - 2401.
[Abstract] [Full Text] [PDF]
S. Sacchi, M. Bernasconi, M. Martineau, J.-P. Mothet, M. Ruzzene, M. S. Pilone, L. Pollegioni, and G. Molla
pLG72 Modulates Intracellular D-Serine Levels through Its Interaction with D-Amino Acid Oxidase: EFFECT ON SCHIZOPHRENIA SUSCEPTIBILITY
J. Biol. Chem., August 8, 2008; 283(32): 22244 - 22256.
[Abstract] [Full Text] [PDF]
D. T. Theodosis, D. A. Poulain, and S. H. R. Oliet
Activity-Dependent Structural and Functional Plasticity of Astrocyte-Neuron Interactions
Physiol Rev, July 1, 2008; 88(3): 983 - 1008.
[Abstract] [Full Text] [PDF]
C. Villmann and C.-M. Becker
On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor
Neuroscientist, December 1, 2007; 13(6): 594 - 615.
[Abstract] [PDF]
E. C. Gustafson, E. R. Stevens, H. Wolosker, and R. F. Miller
Endogenous D-Serine Contributes to NMDA-Receptor-Mediated Light-Evoked Responses in the Vertebrate Retina
J Neurophysiol, July 1, 2007; 98(1): 122 - 130.
[Abstract] [Full Text] [PDF]
H. Wolosker
D-Serine Regulation of NMDA Receptor Activity
Sci. Signal., October 10, 2006; 2006(356): pe41 - pe41.
[Abstract] [Full Text] [PDF]
E. Dumin, I. Bendikov, V. N. Foltyn, Y. Misumi, Y. Ikehara, E. Kartvelishvily, and H. Wolosker
Modulation of D-Serine Levels via Ubiquitin-dependent Proteasomal Degradation of Serine Racemase
J. Biol. Chem., July 21, 2006; 281(29): 20291 - 20302.
[Abstract] [Full Text] [PDF]
E. Kartvelishvily, M. Shleper, L. Balan, E. Dumin, and H. Wolosker
Neuron-derived D-Serine Release Provides a Novel Means to Activate N-Methyl-D-aspartate Receptors
J. Biol. Chem., May 19, 2006; 281(20): 14151 - 14162.
[Abstract] [Full Text] [PDF]
Y. Yao and M. L. Mayer
Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A.
J. Neurosci., April 26, 2006; 26(17): 4559 - 4566.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|